arrow
D

Darin K. Edwards

moderna inc
H指数:35
被引数:8,436

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Germinal center–mediated broadening of B cell responses to SARS-CoV-2 booster immunization

生发中心介导的B细胞对SARS-CoV-2加强免疫应答的广化

2025-10-100
PRE
Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial

下一代mRNA-1283 COVID-19疫苗与mRNA-1273疫苗(NextCOVE)的疗效、免疫原性和安全性比较:一项III期、随机、观察者盲法、活性对照试验的结果

2025-07-070
PRE
mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice

mRNA-1273疫苗针对JN.1或KP.2的变体能够诱导小鼠产生对SARS-CoV-2 JN.1亚系的交叉中和反应。

VACCINE
IF3.5
2025-04-010
OAAI
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection
2024-11-060
PRE
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines
Nature
IF48.5
2024-05-150
PRE
Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
2023-09-2222
OAAI
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2
2023-09-137
PRE
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results
2023-08-3121
OAAI
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later
2023-03-0112
OAAI